Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
Interim guidance
25 January 2021
| COVID-19: Critical preparedness, readiness and response
Overview
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) at its extraordinary meeting on 21 January 2021.
WHO Team
COVAX, WHO Headquarters (HQ)
Editors
World Health Organization
Number of pages
8
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/mRNA-1273/2021.1
Copyright
CC BY-NC-SA 3.0 IGO



